Amyloid Solution Investor
Amyloid Solution is a developer of therapy intended to overcome Alzheimer by developing modifying treatments.
Last Funding Type:
Series B
Funding Status:
Late Stage Venture
Headquarters:
Bundangdong, Kyonggi-do, South Korea
Founded Date:
2017-01-01
Investor Type:
For Profit
Last Funding Date:
2020-04-16
Total Funding:
27439551.0
Technology:
Geroscience
Employee Number:
11-50
Investors Number:
1
Industry:
Biotechnology, Health Care, Therapeutics